CRYSTALLINE SALT FORM OF (S)-(2-(6-CHLORO-7-METHYL-1H-BENZO(D)IMIDAZOL-2-YL)-2-METHYLPYRROLIDIN-1-YL)(5-METHOXY-2-(2H-1,2,3-TRIAZOL-2-YL)PHENYL)METHANONE AS OREXIN RECEPTOR ANTAGONIST

• 收藏
• 分享

专利权人:

Idorsia Pharmaceuticals Ltd

发明人:

BOSS Christoph,BOSS Christoph,BROTSCHI Christine,BROTSCHI Christine,GUDE Markus,GUDE Markus,HEIDMANN Bibia,HEIDMANN Bibia,SIFFERLEN Thierry,SIFFERLEN Thierry,VON RAUMER Markus,VON RAUMER Markus,WILLIA

申请号：

SI201430453

公开号：

SI3077390T1

申请日:

2014.12.02

申请国别(地区):

SI

年份:

2017

代理人:

摘要：

The invention relates to a crystalline form of (S)-(2-(6-chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone hydrochloride, processes for the preparation thereof, pharmaceutical compositions containing said crystalline form, and its use as medicament, especially as orexin receptor antagonist.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/